Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist (Q28242421)
Jump to navigation
Jump to search
scientific article (publication date: August 2012)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist |
scientific article (publication date: August 2012) |
Statements
Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist (English)
0 references
August 2012
0 references
26
0 references
8
0 references
1058-70
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference